[
    [
        {
            "time": "",
            "original_text": "下周操盘策略：4月CPI工业增加值等重磅数据即将发布",
            "features": {
                "keywords": [
                    "CPI",
                    "工业增加值",
                    "重磅数据"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "宏观经济"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "下周操盘策略：4月CPI工业增加值等重磅数据即将发布",
                "Correlation": 3,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 1,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[路演]智飞生物总经理蒲江：宜卡(R) 走向国际",
            "features": {
                "keywords": [
                    "智飞生物",
                    "宜卡",
                    "国际"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[路演]智飞生物总经理蒲江：宜卡(R) 走向国际",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "[路演]智飞生物宜卡(R) 上市 填补国内结核病诊断空白",
            "features": {
                "keywords": [
                    "智飞生物",
                    "宜卡",
                    "结核病",
                    "诊断",
                    "填补空白"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[路演]智飞生物宜卡(R) 上市 填补国内结核病诊断空白",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[路演]方向民：智飞生物结核病防治矩阵已实现中国“智”造",
            "features": {
                "keywords": [
                    "智飞生物",
                    "结核病",
                    "防治矩阵",
                    "中国制造"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "[路演]方向民：智飞生物结核病防治矩阵已实现中国“智”造",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "智飞生物一类新药宜卡上市 全球结核防治迎新诊断利器",
            "features": {
                "keywords": [
                    "智飞生物",
                    "宜卡",
                    "新药",
                    "全球",
                    "结核病",
                    "诊断"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物一类新药宜卡上市 全球结核防治迎新诊断利器",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "我国和全球结核病防治迎来新型诊断工具 智飞生物1类新药宜卡正式上市",
            "features": {
                "keywords": [
                    "智飞生物",
                    "宜卡",
                    "结核病",
                    "新型诊断工具",
                    "全球"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "我国和全球结核病防治迎来新型诊断工具 智飞生物1类新药宜卡正式上市",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "智飞生物董事长蒋仁生：宜卡可解决传统无法鉴别卡介苗接种与结核感染困境",
            "features": {
                "keywords": [
                    "智飞生物",
                    "宜卡",
                    "卡介苗",
                    "结核感染",
                    "困境"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物董事长蒋仁生：宜卡可解决传统无法鉴别卡介苗接种与结核感染困境",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飞生物构建结核病防治矩阵，已有2款上市产品及4款在研产品",
            "features": {
                "keywords": [
                    "智飞生物",
                    "结核病",
                    "防治矩阵",
                    "上市产品",
                    "在研产品"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物构建结核病防治矩阵，已有2款上市产品及4款在研产品",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飞生物：宜卡使用不受实验室条件限制 可实现年产3000万人份生产规模",
            "features": {
                "keywords": [
                    "智飞生物",
                    "宜卡",
                    "实验室条件",
                    "生产规模"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物：宜卡使用不受实验室条件限制 可实现年产3000万人份生产规模",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "智飞生物自研重磅新药宜卡上市，全球首款结核病诊断生物制品",
            "features": {
                "keywords": [
                    "智飞生物",
                    "宜卡",
                    "自研",
                    "重磅新药",
                    "全球首款",
                    "结核病",
                    "诊断"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "智飞生物自研重磅新药宜卡上市，全球首款结核病诊断生物制品",
                "Correlation": 10,
                "Sentiment": 10,
                "Importance": 10,
                "Impact": 10,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 10
            }
        },
        {
            "time": "",
            "original_text": "【e公司直播】智飞生物重组结核杆菌融合蛋白（EC，宜卡）新闻发布会",
            "features": {
                "keywords": [
                    "智飞生物",
                    "重组结核杆菌融合蛋白",
                    "EC",
                    "宜卡",
                    "新闻发布会"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【e公司直播】智飞生物重组结核杆菌融合蛋白（EC，宜卡）新闻发布会",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]